カテゴリ： Transparency Market Research, 医療/バイオ, 日本

消費者直接型（DTC）臨床試験の日本市場2021～2031：検体タイプ別、検査種類別

■ 英語タイトル：Direct-to-Consumer Laboratory Testing Market (Sample Type: Blood, Urine, Saliva, and Others; and Test Type: Genetic Testing, Disease Risk Assessment Testing, CBC, Diabetes Testing, TSH Testing, and Others) - Japan Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031
	■ 発行会社/調査会社：Transparency Market Research ■ 商品コード：TMR22JN081 ■ 発行日：2022年4月 ■ 調査対象地域：日本 ■ 産業分野：医療 ■ ページ数：84 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール（受注後24時間以内）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧）	USD5,795 ⇒換算￥846,070	見積依頼/購入/質問フォーム
Multi User（5名様閲覧）	USD8,795 ⇒換算￥1,284,070	見積依頼/購入/質問フォーム
Corporate License（法人閲覧）	USD11,795 ⇒換算￥1,722,070	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Transparency Market Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[消費者直接型（DTC）臨床試験の日本市場2021～2031：検体タイプ別、検査種類別]についてメールでお問い合わせはこちら

Transparency Market Research社の本調査レポートでは、日本の消費者直接型（DTC）臨床試験市場を調査対象とし、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、検体タイプ別分析、検査種類別分析、地域別分析、競争状況などの内容をまとめております。

*** レポート概要（サマリー）***

Japan Direct-to-Consumer Laboratory Testing Market – Scope of Report
TMR’s report on the direct-to-consumer laboratory testing market in Japan studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the direct-to-consumer laboratory testing market in Japan for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the direct-to-consumer laboratory testing market in Japan from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the direct-to-consumer laboratory testing market in Japan.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the direct-to-consumer laboratory testing market in Japan.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the direct-to-consumer laboratory testing market in Japan. These serve as valuable tools for existing market players as well as for entities interested in participating in the direct-to-consumer laboratory testing market in Japan.

The report delves into the competitive landscape of the direct-to-consumer laboratory testing market in Japan. Key players operating in the direct-to-consumer laboratory testing market in Japan have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the direct-to-consumer laboratory testing market in Japan profiled in this report.

Key Questions Answered in Japan Direct-to-Consumer Laboratory Testing Market Report
What is the sales/revenue generated by direct-to-consumer laboratory testing in Japan during the forecast period?
What are the opportunities in the direct-to-consumer laboratory testing market in Japan?
What are the major drivers, restraints, opportunities, and threats in the market?
Is market set to expand at the fastest CAGR during the forecast period?
Which sample type is expected to generate the highest revenue in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What is the market position of different companies operating in the market?

Japan Direct-to-Consumer Laboratory Testing Market – Research Objectives and Research Approach
The comprehensive report on the direct-to-consumer laboratory testing market in Japan begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the direct-to-consumer laboratory testing market in Japan, in terms of sample type, test type, and region. Key segments under each criterion are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the direct-to-consumer laboratory testing market in Japan.

*** レポート目次（コンテンツ）***

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Japan Direct-to-Consumer Laboratory Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Sample Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Japan Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Disease Epidemiology
5.2. Regulatory Scenario by Country
5.3. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Japan Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Sample Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Sample Type, 2017–2031
6.3.1. Blood
6.3.2. Urine
6.3.3. Saliva
6.3.4. Others
6.4. Market Attractiveness Analysis, by Sample Type
7. Japan Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Test Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Test Type, 2017–2031
7.3.1. Genetic Testing
7.3.2. Disease Risk Assessment Testing
7.3.2.1. Cancer
7.3.2.2. STDs
7.3.2.3. Others
7.3.3. CBC
7.3.4. TSH Testing
7.3.5. Diabetes Testing
7.3.6. Others
7.4. Market Attractiveness Analysis, by Test Type
8. Japan Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. Japan
8.3. Market Attractiveness Analysis, by Country/Region
9. Competition Landscape
9.1. Market Player – Competition Matrix (by tier and size of companies)
9.2. Company Profiles
9.2.1. Quest Diagnostics Incorporated
9.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.1.2. Product Portfolio
9.2.1.3. Financial Overview
9.2.1.4. Strategic Overview
9.2.1.5. SWOT Analysis
9.2.2. WellnessFX
9.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.2.2. Product Portfolio
9.2.2.3. Financial Overview
9.2.2.4. Strategic Overview
9.2.2.5. SWOT Analysis
9.2.3. Ulta Lab Tests, LLC
9.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.3.2. Product Portfolio
9.2.3.3. Financial Overview
9.2.3.4. Strategic Overview
9.2.3.5. SWOT Analysis
9.2.4. Walk-In Lab, LLC
9.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.4.2. Product Portfolio
9.2.4.3. Financial Overview
9.2.4.4. Strategic Overview
9.2.4.5. SWOT Analysis
9.2.5. Genesis Healthcare Co.
9.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.5.2. Product Portfolio
9.2.5.3. Financial Overview
9.2.5.4. Strategic Overview
9.2.5.5. SWOT Analysis
9.2.6. MyHeritage Ltd.
9.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.6.2. Product Portfolio
9.2.6.3. Financial Overview
9.2.6.4. Strategic Overview
9.2.6.5. SWOT Analysis
9.2.7. Gene by Gene, Ltd.
9.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.7.2. Product Portfolio
9.2.7.3. Financial Overview
9.2.7.4. Strategic Overview
9.2.7.5. SWOT Analysis
9.2.8. Full Genomes Corporation, Inc.
9.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.8.2. Product Portfolio
9.2.8.3. Financial Overview
9.2.8.4. Strategic Overview
9.2.8.5. SWOT Analysis
9.2.9. OME Care
9.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.9.2. Product Portfolio
9.2.9.3. Financial Overview
9.2.9.4. Strategic Overview
9.2.9.5. SWOT Analysis

List of Tables

Table 01: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 02: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 03: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 04: Japan Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Country, 2017–2031

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

※関連調査資料

消費者直結臨床検査の北米市場2021年ｰ2031年：検体タイプ別（血液、尿、唾液、その他）、検査タイプ別、エンドユーザー別
TMR21DC057 / Transparency Market Research / 2021年10月13日 / Transparency Market Research社の本調査レポートは、消費者直結臨床検査の北米市場を調査対象とし、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、検体タイプ別分析、検査タイプ別分析、エンドユーザー別分析、国別分析、競争状況などの構成でまとめております。...

非侵襲的出生前検査（NIPT）の世界市場2022～2031：検査種類別、技術別
TMR22NV085 / Transparency Market Research / 2022年9月21日 / Transparency Market Research社の当調査レポートでは、世界の非侵襲的出生前検査（NIPT）市場を総合的に調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、検査種類別（Materni21、ハーモニー、パノラマ、Verifi、NIFTY、その他）分析、技術別（NGS、WGS、その他）分析、用途別（トリソミー症候群、微小欠失症候群、その他）分析、エンドユーザー別（病院、診断研究室、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの内容を掲載しています。なお、当書には、Berry...

新型コロナウイルス感染症用診断の世界市場（2022～2031）：製品別、検査種類別
TMR23AP084 / Transparency Market Research / 2023年1月24日 / Transparency Market Research社の本調査レポートでは、新型コロナウイルス感染症用診断の世界市場について総合的に分析し、今後の市場動向を予測しています。本書は、序論、仮定＆調査手法、エグゼクティブサマリー、市場概要、キーインサイト、市場分析＆予測、製品別（機器、試薬＆キット）分析、検査種類別（分子検査、抗原検査、抗体検査）分析、エンドユーザー別（病院＆クリニック、家庭用、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの項目が整理されています。また、本書内には、Abbott...

がん診断の世界市場2022～2031：検査種類別、エンドユーザー別
TMR23JN029 / Transparency Market Research / 2022年10月21日 / Transparency Market Research社の市場調査資料では、世界のがん診断市場を広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要インサイト、検査種類別（腫瘍バイオマーカー検査、画像診断、内視鏡検査、生体検査）分析、用途別（乳がん、肺がん、大腸がん、前立腺がん、その他がん）分析、エンドユーザー別（病院、外来手術センター、診断研究所、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況など、以下の構成でのまとめています。さらに、本調査資料には、Abbott、Agilent...

中東・アフリカの消費者直結型臨床検査市場2021年ｰ2031年：検査種類別（遺伝子検査、疾病リスク評価検査、CBC、慢性疾患検査、新型コロナウイルス感染症検査、TSH検査、その他）、検体種類別、提供者別
TMR22FB060 / Transparency Market Research / 2021年11月 / Transparency Market Research社の本調査レポートは、中東・アフリカの消費者直結型臨床検査市場を調査対象とし、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、検体種類別分析、検査種類別分析、提供者別分析、地域別分析、競争状況などの構成でまとめています。...

※注目の調査資料

※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(TMR22JN081 )"消費者直接型（DTC）臨床試験の日本市場2021～2031：検体タイプ別、検査種類別" (英文：Direct-to-Consumer Laboratory Testing Market (Sample Type: Blood, Urine, Saliva, and Others; and Test Type: Genetic Testing, Disease Risk Assessment Testing, CBC, Diabetes Testing, TSH Testing, and Others) - Japan Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031)はTransparency Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

◆H&Iグローバルリサーチのお客様（例）◆